Predictions
Carbylan Therapeutics Inc
Start price
Target price
Perf. (%)
€8.10
27.06.23
27.06.23
€12.00
31.07.26
31.07.26
74.07%
04.02.24
04.02.24
Could be very worthwhile Investment >20% year
Kura Oncology Inc
Start price
Target price
Perf. (%)
€17.70
25.01.24
25.01.24
€16.00
31.08.25
31.08.25
9.60%
02.02.24
02.02.24
Could be very worthwhile Investment >20% year
Novavax Inc.
Start price
Target price
Perf. (%)
€11.01
11.01.23
11.01.23
€6.00
11.01.24
11.01.24
-61.64%
12.01.24
12.01.24
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€529.00
18.12.23
18.12.23
€558.00
18.12.24
18.12.24
6.62%
06.01.24
06.01.24
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Amgen Inc.
Start price
Target price
Perf. (%)
€246.80
19.09.23
19.09.23
€250.00
19.09.24
19.09.24
4.13%
27.09.23
27.09.23
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Amgen Inc.
Start price
Target price
Perf. (%)
€246.80
19.09.23
19.09.23
€250.00
19.09.24
19.09.24
4.13%
27.09.23
27.09.23
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Amgen Inc.
Start price
Target price
Perf. (%)
€246.80
19.09.23
19.09.23
€250.00
19.09.24
19.09.24
4.13%
27.09.23
27.09.23
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€502.50
17.08.23
17.08.23
€510.00
17.08.24
17.08.24
10.75%
13.09.23
13.09.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Johnson & Johnson
Start price
Target price
Perf. (%)
€152.60
24.07.23
24.07.23
€155.00
24.07.24
24.07.24
3.47%
16.08.23
16.08.23
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Johnson & Johnson
Start price
Target price
Perf. (%)
€152.60
24.07.23
24.07.23
€155.00
24.07.24
24.07.24
3.47%
16.08.23
16.08.23
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Novo Nordisk A/S
Start price
Target price
Perf. (%)
€100.76
08.08.22
08.08.22
€120.00
08.08.23
08.08.23
69.31%
09.08.23
09.08.23
Axsome Therapeutics Inc
Start price
Target price
Perf. (%)
€60.00
08.09.22
08.09.22
€80.00
31.12.24
31.12.24
35.00%
24.06.23
24.06.23
Could be very worthwhile Investment >20% year
MorphoSys AG
Start price
Target price
Perf. (%)
€18.69
12.06.22
12.06.22
€28.00
12.06.23
12.06.23
53.93%
13.06.23
13.06.23
Could be worthwhile Investment >10% per year
MorphoSys AG
Start price
Target price
Perf. (%)
€18.69
12.06.22
12.06.22
€28.00
12.06.23
12.06.23
53.93%
13.06.23
13.06.23
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€388.00
05.05.23
05.05.23
€395.00
05.05.24
05.05.24
3.52%
12.05.23
12.05.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Seagen Inc.
Start price
Target price
Perf. (%)
€165.90
15.08.22
15.08.22
€180.00
31.01.24
31.01.24
9.64%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Seagen Inc.
Start price
Target price
Perf. (%)
€165.90
15.08.22
15.08.22
€180.00
31.01.24
31.01.24
9.64%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€16.10
07.05.22
07.05.22
€20.00
07.05.23
07.05.23
222.26%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.50
03.01.23
03.01.23
€30.00
31.12.25
31.12.25
76.00%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€16.97
06.02.23
06.02.23
€27.00
31.12.25
31.12.25
87.64%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year